Design, 3D QSAR modeling and docking of TGF-β type I inhibitors to target cancer
暂无分享,去创建一个
K. Saravanan | T. V. Ajay Kumar | Alias Anand S. Athavan | C. Loganathan | S. Kabilan | V. Parthasathy | K. Saravanan | V. Parthasarathy | S. Kabilan | T. V. A. Kumar | C. Loganathan | V. Parthasathy
[1] David E. Shaw,et al. PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results , 2006, J. Comput. Aided Mol. Des..
[2] Brian K. Shoichet,et al. ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..
[3] Donald B. Boyd,et al. Successes of Computer‐Assisted Molecular Design , 2007 .
[4] Scott R Granter,et al. EWI-2 negatively regulates TGF-β signaling leading to altered melanoma growth and metastasis , 2015, Cell Research.
[5] Dae-Kee Kim,et al. Synthesis and biological evaluation of 4(5)-(6-alkylpyridin-2-yl)imidazoles as transforming growth factor-beta type 1 receptor kinase inhibitors. , 2007, Journal of medicinal chemistry.
[6] David Calkins,et al. Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution , 2010, J. Comput. Aided Mol. Des..
[7] Anita B. Roberts,et al. Tumor suppressor activity of the TGF-β pathway in human cancers , 1996 .
[8] Ruth Lehr,et al. Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5). , 2002, Journal of medicinal chemistry.
[9] Baidurya Bhattacharya,et al. Nonergodicity of the Nose-Hoover chain thermostat in computationally achievable time. , 2014, Physical review. E, Statistical, nonlinear, and soft matter physics.
[10] Zhili Zuo,et al. Docking study and three-dimensional quantitative structure-activity relationship (3D-QSAR) analyses of transforming growth factor-ß type I receptor kinase inhibitors , 2009 .
[11] Hege S. Beard,et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.
[12] Shanthi Nagarajan,et al. Homology modeling, molecular dynamics, e-pharmacophore mapping and docking study of Chikungunya virus nsP2 protease , 2011, Journal of Molecular Modeling.
[13] Oliver Eickelberg,et al. The impact of TGF-β on lung fibrosis: from targeting to biomarkers. , 2012, Proceedings of the American Thoracic Society.
[14] A. Hata,et al. Targeting the TGFβ signalling pathway in disease , 2012, Nature Reviews Drug Discovery.
[15] Ying E. Zhang,et al. Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.
[16] J. Massagué,et al. How cells read TGF-β signals , 2000, Nature Reviews Molecular Cell Biology.
[17] Sahaya Asirvatham,et al. Quantitative structure activity relationships studies of non-steroidal anti-inflammatory drugs: A review , 2016, Arabian Journal of Chemistry.
[18] Woody Sherman,et al. ConfGen: A Conformational Search Method for Efficient Generation of Bioactive Conformers , 2010, J. Chem. Inf. Model..
[19] D. Kingsley,et al. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. , 1994, Genes & development.
[20] W. L. Jorgensen,et al. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. , 1988, Journal of the American Chemical Society.
[21] T. Darden,et al. A smooth particle mesh Ewald method , 1995 .
[22] A. De,et al. In silico Analysis of 3D-QSAR and Molecular Docking for Bcl-2 Inhibitors to Potential Anticancer Drug Development , 2013 .
[23] Richard A. Friesner,et al. Flexible ligand docking with Glide. , 2007, Current protocols in bioinformatics.
[24] Jian Luo,et al. Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1. , 2013, Journal of the National Cancer Institute.
[25] W. L. Jorgensen,et al. Temperature dependence of TIP3P, SPC, and TIP4P water from NPT Monte Carlo simulations: Seeking temperatures of maximum density , 1998 .
[26] I. Kuntz,et al. Automated docking with grid‐based energy evaluation , 1992 .
[27] Alexander Tropsha,et al. Best Practices for QSAR Model Development, Validation, and Exploitation , 2010, Molecular informatics.
[28] T. Cheatham,et al. Convergence and reproducibility in molecular dynamics simulations of the DNA duplex d(GCACGAACGAACGAACGC). , 2015, Biochimica et biophysica acta.
[29] K. Muthusamy,et al. Ligand-based Pharmacophore Modeling; Atom-based 3D-QSAR Analysis and Molecular Docking Studies of Phosphoinositide-Dependent Kinase-1 Inhibitors , 2012, Indian journal of pharmaceutical sciences.
[30] Françoise Gellibert,et al. Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-beta type I receptor inhibitors. , 2004, Journal of medicinal chemistry.
[31] Ya-wen Wang,et al. Pharmacophore modeling and 3D-QSAR analysis of phosphoinositide 3-kinase p110α inhibitors , 2010, Journal of molecular modeling.
[32] Werner J Geldenhuys,et al. 3D-QSAR and docking studies on transforming growth factor (TGF)-beta receptor 1 antagonists. , 2010, Bioorganic & medicinal chemistry letters.
[33] R. McAnulty,et al. TGF-beta: its role in asthma and therapeutic potential. , 2006, Current drug targets.
[34] Richard A. Friesner,et al. Comparative Performance of Several Flexible Docking Programs and Scoring Functions: Enrichment Studies for a Diverse Set of Pharmaceutically Relevant Targets , 2007, J. Chem. Inf. Model..
[35] Steven L Dixon,et al. PHASE: A Novel Approach to Pharmacophore Modeling and 3D Database Searching , 2006, Chemical biology & drug design.
[36] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[37] A. Tedgui,et al. Inhibition of Transforming Growth Factor- Signaling Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Mice , 2001 .
[38] George W. A. Milne,et al. National Cancer Institute Drug Information System 3D Database , 1994, J. Chem. Inf. Comput. Sci..
[39] David A. Evans,et al. 3D QSAR Methods: Phase and Catalyst Compared , 2007, J. Chem. Inf. Model..
[40] Tao Wang,et al. Quantitative structure–activity relationship: promising advances in drug discovery platforms , 2015, Expert opinion on drug discovery.
[41] Woody Sherman,et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.
[42] K. Saravanan,et al. Comparison of Molecular Docking and Molecular Dynamics Simulations of 1,3-Thiazin-4-One with MDM2 Protein , 2015, International Letters of Chemistry, Physics and Astronomy.
[43] Xin Wen,et al. BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..
[44] Ester Piek,et al. Role of Transforming Growth Factor-β Signaling in Cancer , 2000 .